Delivery Order SPE2DB24D2011-SPE2DB25FBQBE
Award Date
2/20/25
Potential Completion Date
2/21/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,613.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to be completed by June 17, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $7,303.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the vaccine ENGERIX-B 20 MCG/ML SYRNML. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award, valued at $3,503.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract involves the delivery of ENGERIX-B 20 MCG/ML SYRNML medical supplies, with an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $52,204.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the provision of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product, with a completion date of January 28, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products to the Defense Logistics Agency (DLA). The $9,129.99 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award, valued at $9,109.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product. The award has an ultimate completion date of January 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,016.55 firm fixed-price delivery order is for ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML vaccine to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The $1,400.76 firm fixed-price delivery order contract has a completion date of December 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $23,447.05 firm-fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with an ultimate completion date of August 13, 2024. This contract does not have a set-aside designation. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,685.20, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at...